Novel treatment strategies for relapsed and refractory Hodgkin lymphoma in immunotherapy era.
10.3760/cma.j.issn.0253-2727.2019.04.019
- Author:
Wen Yan YU
1
;
Jian Qing MI
Author Information
1. State Key Laboratory for Medical Genomics and Department of Hematology, Shanghai Institute of Hematology, Collaborative Innovation Center of Systems Biomedicine, Pôle Sino-Français des Sciences du Vivant et Genomique, Rui Jin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
- Publication Type:Journal Article
- MeSH:
Antineoplastic Combined Chemotherapy Protocols;
Hodgkin Disease;
Humans;
Immunoconjugates;
Immunotherapy
- From:
Chinese Journal of Hematology
2019;40(4):348-352
- CountryChina
- Language:Chinese
